Method Briefs · The Method Register
Advanced experimental strategies and analytical frameworks. Each brief is backed by a live BioSkepsis research conversation. Open it in the app to drill into specific protocols, compare techniques, or adapt the methodology to your own dataset.
Featured brief · 12/06/2026
PET, MRI, BLI, and fluorescence imaging compared for tracking adoptive cell therapies in vivo. Resolution, sensitivity, and clinical validation reviewed.
Read the brief
Protocols for CRISPR base editing and prime editing in staple crops: guide RNA design, RNP delivery, off-target profiling, and field trial validation standards.
How nnU-Net, VGG16-MLP-Mixer, and radiomics-DL fusion models segment thymic tissue from routine CT scans and predict thymoma risk across multi-center cohorts.
How SLICE-based CRISPR screens identify transcription factor regulators of T cell exhaustion in CAR-T cells using TFome libraries and multi-omic readouts.
How spatial transcriptomics resolves cellular heterogeneity that bulk RNA-seq and scRNA-seq miss, from 10x Visium deconvolution to subcellular imaging.
How cfDNA methylation, fragmentomics, and protein biomarkers combine in MCED blood tests to detect early-stage tumors across 50+ cancer types.
How organ-on-chip platforms predict human drug toxicity across liver, heart, lung, and BBB models, with 87% DILI sensitivity and PBPK integration.
Resolution and sensitivity tradeoffs between Visium, MERFISH, and Slide-seq for tumor-immune interface mapping, subcellular platforms, causal validation with Perturb-FISH, and clinical translation of spatial transcriptomics.
How AlphaFold 3 is used for PROTAC ternary complex prediction and binding site discovery, its confidence metric limitations, and the experimental validation cascade that catches in silico failures.
Best-practice workflows for integrating MALDI mass spectrometry imaging with Visium spatial transcriptomics, covering same-section and adjacent-section strategies, computational registration tools, and mechanistic validation.
